Standard Therapy
Standard Therapy is a pharmaceutical drug with 151 clinical trials. Currently 17 active trials ongoing. Historical success rate of 83.1%.
Success Metrics
Based on 69 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
36
Mid Stage
37
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
69 of 92 finished
25.0%
23 ended early
17
trials recruiting
151
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults
Modified Huanglian Wendan Decoction for Metabolic Syndrome
Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases
The EPIVER Randomized Controlled Trial
Effects of Snoezelen Multisensory Therapy on Older Adults With Dementia
Clinical Trials (151)
Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults
Modified Huanglian Wendan Decoction for Metabolic Syndrome
Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases
The EPIVER Randomized Controlled Trial
Effects of Snoezelen Multisensory Therapy on Older Adults With Dementia
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Multi-field Functional Electrical Stimulation for Distal Upper-limb Rehabilitation After Subacute Stroke: a Pilot Randomised Controlled Trial
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
iNO300 Therapy in Critically Ill Patients With Pneumonia
VirtualPark_Pediatric
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Stem Cell and Conditioned Medium for Cerebral Palsy
Application of mRNA Immunotherapy Technology in EB Virus Related Diseases
Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in Children
Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy
Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 151